SAVA (cassavasciences.com) Sof daromad

SAVA (cassavasciences.com) - kompaniyaning tovar belgisi

Cassava Sciences, Inc. (SAVA) simufilam dori vositasi orqali Altsgeymerga qarshi kurashish uchun miya oqsillarini tiklashga e'tibor qaratadi. Kompaniyaning sof foydasi bozor konsensusi bilan uyg'unlikni aks ettiradi, bunda oxirgi ko'rsatkich -0.10 ni tashkil etadi. Kompaniya hozirda o'z kelajagini belgilovchi muhim 3-fazali sinovlarni yakunlamoqda. Yuqori R&D xarajatlari va FDA ning qat'iy nazorati yangi ishtirokchilar uchun kirishning sezilarli to'siqlarini yaratadi.

Cassava Sciences, Inc. (SAVA) Kompaniyaning sof foydasi: 04.07.2022 - 11.03.2026 davri uchun

Cassava Sciences (SAVA) moliyaviy va bozor koʻrsatkichlari kesimi

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Cassava Pharma|SAVA - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor bahosi Cassava Pharma|SAVA - Korxona qiymati
- kompaniyaning balans qiymati tafsilotlari:
Bitta aksiya hisobiga balans qiymati Cassava Sciences|SAVA - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor kapitallashuvi cassavasciences.com|SAVA - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Umumiy qarzning kapitalga nisbati koeffitsiyenti Cassava Sciences, Inc.|SAVA - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati Cassava Sciences Inc|SAVA - Kompaniyaning umumiy qarzi|Qarzning balans kapitallashuviga nisbati Cassava Pharma|SAVA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Cassava Sciences|Oraliq qoplash koeffitsiyenti cassavasciences.com
- foyda va bozor multiplikatorlari tafsilotlari:
SAVA - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:Cassava Pharma, SAVA
Cassava Sciences seriyali mahsuloti

Alzheimer kasalligi terapiyasining ishlab chiqilishi Cassava Sciences, Inc. (SAVA) biznesini bozor sikllariga sezgir bo'lmagan, ammo klinik sinovlar natijalariga juda bog'liq qiladi. Foyda miqdorining ushbu tendentsiyasi joriy kotirovkalarga asoslangan kunlik sof daromadni aks ettirib, investorlarga obyektiv moliyaviy natijalarni spekulyativ kutishlardan ajratish va cho'qqi nuqtalarda sotib olayotganda kapital yo'qotish xavfini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof daromad regencellbioscience.com (RGC)|Sof foyda AXSM|Sof foyda ACADIA Pharma (ACAD)|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Sof moliyaviy natija Viking Therapeutics Corp (VKTX)|SUPN - Kompaniyaning sof foydasi|Sof moliyaviy natija catalystpharma.com CPRX|DNLI: Sof foyda|Harmony Biosciences Inc (HRMY) - Sof foyda|Sof daromad BHVN|Kompaniyaning sof foydasi AMLX|Sof foyda TRVI|Sof foyda praxismedicines.com (PRAX)|Anavex Life Sciences Corp. - Sof daromad|Yakuniy foyda CBLL|PRTA - Kompaniyaning sof foydasi|Sof moliyaviy natija Alector, Inc. ALEC|ANNX: Sof foyda|Sof daromad Omeros|NGNE (Neurogene) - Sof foyda|AC Immune S.A. (ACIU) - Sof moliyaviy natija|Sof foyda VYGR|NMRA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Scilex Holding Company SCLX|TVGN: Kompaniya foydasi|Alpha Cognition Corp - Sof foyda|cogrx.com (CGTX) - Sof daromad|IKT: Sof foyda|Kompaniyaning sof daromadi Assertio (ASRT)|Kompaniyaning sof foydasi Coya Therapeutics Inc|VistaGen Therapeutics Inc (VTGN) - Sof moliyaviy natija|Sof daromad OVID (Ovid Therapeutics Inc.)|ABOS (Acumen Pharmaceuticals Inc.) - Yakuniy foyda|Sof foyda CRVO (CervoMed Inc)|Sof moliyaviy natija Alterity Therapeutics Ltd. (ATHE)|CLNN - Kompaniyaning sof foydasi|PEPG (PepGen Inc.) - Kompaniya foydasi|JUNS: Sof foyda|Sof daromad Relmada Therapeutics Inc|Sof daromad ANVS|Grace Tx (GRCE) - Sof moliyaviy natija|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Sof moliyaviy natija anewmeds.com|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|Sof foyda Reviva Pharmaceuticals Holdings Inc. RVPH|MTVA: Sof daromad|NRXS: Kompaniyaning sof foydasi|HSDT: Sof foyda|Passage Bio (PASG) - Sof foyda|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Sof foyda ATHA|ADXN - Kompaniyaning sof daromadi|Alzamend Neuro - Sof daromad|Sof foyda Cyclerion Therapeutics Inc. CYCN|PTIX - Kompaniyaning sof foydasi|Yakuniy foyda KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|BCLI (Brainstorm Cell) - Sof foyda|Sof daromad caratherapeutics.com (CARA)|Sof foyda CHRO|Sof foyda eliemtx.com (ELYM)|Kompaniyaning sof foydasi Intra-Cellular Therapies, Inc. ITCI|Sof moliyaviy natija Longboard (LBPH)|MRNS - Kompaniyaning sof foydasi|Sof moliyaviy natija nkgenbiotech.com NKGN|NRBO: Sof foyda|Sage Therapeutics Inc. (SAGE) - Sof foyda|Sof daromad SNPX|Kompaniyaning sof foydasi TRVN|Sof foyda VIGL|Sof foyda Anew Medical Inc. (WENA)|Cerevel Therapeutics, Inc. - Sof daromad